For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Cambridge

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.

Type
D - Journal article
Title of journal
J Clin Invest
Article number
-
Volume number
118
Issue number
8
First page of article
2929
ISSN of journal
0021-9738
Year of publication
2008
URL
-
Number of additional authors
6
Additional information

Justification Statement

(A) The author made a significant contribution to

(i) the conception and design of the study

(ii) the organisation and conduct of the study

(iv) analysis and interpretation of study data

and

(B) the author helped

(i) draft the output

(ii) critique the output for important intellectual content

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
11
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-